Olive Garden is set to introduce GLP-1-friendly menu options and opportunities for free food in 2026. The announcement came during the Q3 FY2026 earnings call from Olive Garden's parent company, Darden Restaurants. The company saw a 4.7% increase in total sales during the quarter, largely driven by menu changes and delivery fees. Over the past few months, Olive Garden has been testing smaller portion sizes at some locations and plans to roll them out nationwide over the next year. The new menu offers additional smaller portions of popular dishes at a lower price and is offered in addition to the regular portion sizes. A September 2025 report from the RAND Corporation found that nearly 12% of American adults had taken GLP1 drugs for weight loss, and another 14% were interested in doing so.